Inventor
Tarik Soliman
Inventor
Cambridge, MA, US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes45%
C07KPeptides32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C12NMicroorganisms or enzymes5%
PatentTitleYear
11,116,816Therapeutic vitamin d conjugates202110,702,574Therapeutic vitamin D conjugates202010,420,819Insulin vitamin D conjugates201910,406,202Therapeutic vitamin D conjugates20199,884,124'Carriers for improved drug delivery'20189,789,197'RNAi vitamin D conjugates'20179,616,109'Insulin vitamin D conjugates'20179,585,934'Therapeutic vitamin D conjugates'20179,289,507'Carriers for improved drug delivery'20169,173,950'Vitamin D-ghrelin conjugates'20158,137,928'Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms'20128,043,833'Expression of soluble therapeutic proteins'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011Patents assigned to NOVO NORDISK AS (1)· patent assignee history
2011–2012Based in Chester Springs, PA, US· patent location history
2012Patents assigned to BioGeneriX (1)· patent assignee history
2012Patents assigned to SCHWARTZ MARC F (1)· patent assignee history
2012Patents assigned to SOLIMAN TARIK (1)· patent assignee history
2015–2021Patents assigned to EXTEND BIOSCIENCES INC (10)· patent assignee history
2015–2021Based in Cambridge, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| EXTEND BIOSCIENCES INC | 10 | 2015–2021 |
| BioGeneriX | 1 | 2012 |
| NOVO NORDISK AS | 1 | 2011 |
| SCHWARTZ MARC F | 1 | 2012 |
| SOLIMAN TARIKself | 1 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Cambridge, Massachusetts, US | 10 | 2015–2021 |
| Chester Springs, Pennsylvania, US | 2 | 2011–2012 |